Search results for: 'supplements for obesity'

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...

The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...

Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...

Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...

Magnesium is the second most essential mineral and functions as a cofactor in more than 300 enzyme reactions that regulate various biochemical functions, including muscle and nerve contractions, blood glucose and blood pressure control, and protein synthesis, among others. The mineral is not only essential for maintaining healthy bone and joint he...

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

This research service covers the Anti-obesity Prescription Markets across the United States for the perios 2002 through 2012. The research service provides a detailed analysis of the revenue structure across therapies. Strategic recommendations for these have also been discussed along with revenue forecasts.

This research service examines the European obesity surgery devices markets in terms of the challenges faced by market participants, drivers and restraints in the industry, the competitive structure in the major markets, the revenue forecasts,growth rates and strategic recommendations.

This study provides a detailed introduction and overview of the European dietary supplements market. It offers a comprehensive insight to the dietary supplements industry, its structure, and developments related to it. It clearly lists and defines the market drivers and restraints that have had an impact in the Europe scenario. General health issue...